Does LATANOPROST Cause Product packaging quantity issue? 108 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Product packaging quantity issue have been filed in association with LATANOPROST (IYUZEH). This represents 0.7% of all adverse event reports for LATANOPROST.
108
Reports of Product packaging quantity issue with LATANOPROST
0.7%
of all LATANOPROST reports
0
Deaths
3
Hospitalizations
How Dangerous Is Product packaging quantity issue From LATANOPROST?
Of the 108 reports, 3 (2.8%) required hospitalization.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LATANOPROST. However, 108 reports have been filed with the FAERS database.
What Other Side Effects Does LATANOPROST Cause?
Treatment failure (5,781)
Drug ineffective (1,338)
Eye irritation (1,165)
Eye pain (668)
Hypersensitivity (668)
Ocular hyperaemia (587)
Intraocular pressure increased (579)
Vision blurred (564)
Cataract (546)
Visual impairment (382)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which LATANOPROST Alternatives Have Lower Product packaging quantity issue Risk?
LATANOPROST vs LATANOPROSTENE BUNOD
LATANOPROST vs LATANOPROST\NETARSUDIL
LATANOPROST vs LATANOPROST\TIMOLOL
LATANOPROST vs LATISSE
LATANOPROST vs LATUDA